A
Anders Granholm
Researcher at University of Copenhagen
Publications - 97
Citations - 3145
Anders Granholm is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 14, co-authored 62 publications receiving 1605 citations. Previous affiliations of Anders Granholm include Copenhagen University Hospital.
Papers
More filters
Journal ArticleDOI
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
Sterne Jac.,Srinivas Murthy,Janet V. Diaz,Arthur S. Slutsky,Judit Villar,Derek C. Angus,Djillali Annane,Azevedo Lcp.,Otavio Berwanger,Alexandre Biasi Cavalcanti,Dequin P-F.,Dequin P-F.,Bin Du,Jonathan Emberson,David Fisher,Bruno Giraudeau,Anthony C. Gordon,Anders Granholm,Cameron Green,Richard Haynes,N Heming,Higgins Jpt.,Higgins Jpt.,Peter Horby,Peter Jüni,Martin J Landray,A. Le Gouge,Marie Leclerc,Wei Shen Lim,Flávia Ribeiro Machado,Colin McArthur,Colin McArthur,Ferhat Meziani,Morten Hylander Møller,Anders Perner,M W Petersen,Jelena Savović,Jelena Savović,Bruno Martins Tomazini,Viviane C Veiga,Steven A R Webb,John C. Marshall +41 more
TL;DR: A prospective meta-analysis that pooled data from 7 randomized clinical trials that evaluated the efficacy of corticosteroids in 1703 critically ill patients with COVID-19 found that low-dose dexamethasone reduced mortality in hospitalized patients with Cohen's disease who required respiratory support.
Journal ArticleDOI
Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU
Mette Krag,Mette Krag,Søren Marker,Søren Marker,Anders Perner,Anders Perner,Jørn Wetterslev,Jørn Wetterslev,Matt P. Wise,Joerg C. Schefold,Frederik Keus,Anne Berit Guttormsen,Stepani Bendel,Mark Borthwick,Theis Lange,Theis Lange,Theis Lange,Bodil Steen Rasmussen,Martin Siegemund,Martin Siegemund,Helle Bundgaard,Thomas Elkmann,Jacob V. Jensen,Rune D. Nielsen,Lisbeth Liboriussen,Morten H. Bestle,Jeanie M. Elkjær,Dorte Fris Palmqvist,Minna Bäcklund,Jon Henrik Laake,Per Martin Bådstøløkken,Juha Grönlund,Olena Breum,Akil Walli,Robert Winding,Susanne Iversen,Inge-Lise Jarnvig,Jonathan White,Björn A. Brand,Martin Bruun Madsen,Lars Quist,Klaus J. Thornberg,Anders Møller,Jørgen Wiis,Anders Granholm,Carl Thomas Anthon,Tine Sylvest Meyhoff,Peter Buhl Hjortrup,Søren R. Aagaard,Jo B. Andreasen,Christina A. Sørensen,Pernille Haure,Jacob Hauge,Alexa Hollinger,Jonas Scheuzger,Daniel Tuchscherer,Thierry Vuilliomenet,Jukka Takala,Stephan M. Jakob,Marianne L. Vang,Kim B. Pælestik,Karen L.D. Andersen,Iwan C. C. van der Horst,Willem Dieperink,Jesper Fjølner,Cilia K.W. Kjer,Christine Sølling,Christoffer Sølling,Johanna Karttunen,Matt Morgan,Brit Sjøbø,Janus Engstrøm,Birgit Agerholm-Larsen,Morten Hylander Møller +73 more
TL;DR: Among adult patients in the ICU who were at risk for gastrointestinal bleeding, mortality at 90 days and the number of clinically important events were similar in those assigned to pantoprazole and those assignedto placebo.
Journal ArticleDOI
Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis
Sofie Louise Rygård,Ethan Butler,Anders Granholm,Morten Hylander Møller,Jeremy Cohen,Jeremy Cohen,Simon Finfer,Simon Finfer,Anders Perner,John Myburgh,John Myburgh,John Myburgh,Balasubramanian Venkatesh,Balasubramanian Venkatesh,Anthony Delaney,Anthony Delaney +15 more
TL;DR: In adults with septic shock treated with low dose corticosteroids, short- and longer-term mortality are unaffected, adverse events increase, but duration of shock, mechanical ventilation and ICU stay are reduced.
Journal ArticleDOI
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
Marie Warrer Munch,Sheila Nainan Myatra,Bharath Kumar Tirupakuzhi Vijayaraghavan,Sanjith Saseedharan,Thomas Benfield,Rebecka Rubenson Wahlin,Bodil Steen Rasmussen,Anne Sofie Andreasen,Lone Musaeus Poulsen,Luca Cioccari,Mohd Saif Khan,Farhad N Kapadia,Jigeeshu V Divatia,Anne Craveiro Brøchner,Morten H. Bestle,Marie Helleberg,Jens Michelsen,Ajay Padmanaban,Neeta Bose,Anders Pape Møller,Kapil Borawake,Klaus Tjelle Kristiansen,Urvi Shukla,Michelle S Chew,Subhal Dixit,Charlotte Suppli Ulrik,Pravin Amin,Rajesh Chawla,Christian A Wamberg,Mehul S Shah,Iben S Darfelt,Vibeke Lind Jørgensen,Margit Smitt,Anders Granholm,Maj-Brit Nørregaard Kjaer,Morten Hylander Møller,Tine Sylvest Meyhoff,Gitte Kingo Vesterlund,Naomi E Hammond,Naomi E Hammond,Sharon Micallef,Abhinav Bassi,Oommen John,Oommen John,Anubhuti Jha,Maria Cronhjort,Stephan M. Jakob,Christian Gluud,Christian Gluud,Theis Lange,Vaijayanti Kadam,Klaus Marcussen,Jacob Hollenberg +52 more
TL;DR: In this article, the effects of 12 mg vs 6 mg/d of dexamethasone in patients with COVID-19 and severe hypoxemia were evaluated in a randomized clinical trial at 26 hospitals in Europe and India.